Quality of Life in Patients with Idiopathic Intracranial Hypertension and the Impact of the COVID-19 Pandemic

References

• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127.
   PubMed Web of Science ®Google Scholar
• Sahin S, Karsıdag S, Cınar N, et al. The impact of the COVID-19 lockdown on the quality of life in chronic neurological diseases: the results of a COVQoL-CND. Study Eur Neurol. 2021;84:450–459. doi:10.1159/000517380.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–1165. doi:10.1212/WNL.0b013e3182a55f17.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–1495. doi:10.1212/01.WNL.0000029570.69134.1B.
   PubMed Web of Science ®Google Scholar
• Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45:13–18. doi:10.1136/jnnp.45.1.13.
   PubMed Web of Science ®Google Scholar
• WHO. Wellbeing Measures in Primary Health care/The Depcare Project. Copenhagen: WHO Regional Office for Europe; 1998.
   Google Scholar
• Schmidt S, Muhlan H, Power M. The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study. Eur J Public Health. 2005;16(4):420–428. doi:10.1093/eurpub/cki155.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25- item National Eye Institute visual function questionnaire. Arch Ophthalmol. 2001;119(7):1050–1058. doi:10.1001/archopht.119.7.1050.
   PubMed Web of Science ®Google Scholar
• Bayliss MS, Dewey JE, Dunlap I, et al. A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT). Qual Life Res. 2003;12:953–961. doi:10.1023/A:1026167214355.
   PubMed Web of Science ®Google Scholar
• Ahorsu DK, Lin CY, Imani V, et al. The fear of COVID- 19 scale: development and initial validation. Int J Ment Health Addict. 2020;27:1–9.
   Google Scholar
• Eser E, Çevik C, Baydur H, et al. Reliability and Validity of the Turkish version of the WHO −5, In adults for its use in primary care setting. Primary Health Care Res Dev. 2019;20:1–7. doi:10.1017/S1463423619000343.
   Web of Science ®Google Scholar
• Eser E, Cengiz E, Baydur H, et al. EUROHIS (WHOQOL-8 Tr) Türkçe sürümünün Türk Toplumundaki Psikometrik özellikleri. Turk J Public Health January. 2010;8(3):156–170.
   Google Scholar
• Toprak AB, Eser E, Guler C, et al. Cross-validation of the Turkish version of the 25-item national eye institute visual functioning questionnaire (NEI-VFQ 25. Ophthalmic Epidemiol. 2005;12(4):259–269. doi:10.1080/09286580590967763.
   PubMed Web of Science ®Google Scholar
• Dikmen PY, Günes M, Bozdağ M, et al. Reliability and validity of Turkish version of headache impact test (HIT-6) in patients with migraine. Noro Psikiyatr Ars. 2020;58(4):300–307. doi:10.29399/npa.24956.
   PubMedGoogle Scholar
• Ladikli N, Bahadır E, F.n Y, et al. Covid-19 Korkusu Ölçeği’nin Türkçe Güvenirlik ve Geçerlik Çalışması. Uluslararası Sosyal Bilimler Dergisi. 2020;3(2):71–80.
   Google Scholar
• Friedman DI, McDermott MP, Kieburtz K, et al. The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuro-Ophthalmol. 2014;34:107–117. doi:10.1097/WNO.0000000000000114.
   PubMed Web of Science ®Google Scholar
• Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand. 2010;121:71–82. doi:10.1111/j.1600-0404.2009.01172.x.
   PubMed Web of Science ®Google Scholar
• Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from 5 to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461–474.
   PubMedGoogle Scholar
• Digre KB, Bruce BB, McDermott MP, et al. On behalf of the NORDIC idiopathic intracranial hypertension study group quality of life in idiopathic intracranial hypertension at diagnosis IIH treatment trial results. Neurology. 2015;84(24):2449–2456. doi:10.1212/WNL.0000000000001687.
   PubMed Web of Science ®Google Scholar
• Daniels A, Liu G, Volpe N, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri. Am J Ophthalmol. 2007;143:635–641. doi:10.1016/j.ajo.2006.12.040.
   PubMed Web of Science ®Google Scholar
• Forhan M, Gill SV. Obesity, functional mobility and quality of life. Best Pract Res Clin Endocrinol Metab. 2013;27:129–137. doi:10.1016/j.beem.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Taylor VH, Forhan M, Vigod SN, et al. The impact of obesity on quality of life. Best Pract Res Clin Endocrinol Metab. 2013;27:139–146. doi:10.1016/j.beem.2013.04.004.
   PubMed Web of Science ®Google Scholar
• Burkert NT, Freidl W, Muckenhuber J, et al. Self-perceived health, quality of life, and health-related behavior in obesity: is social status a mediator? Wien Klin Wochenschr. 2012;124:271–275. doi:10.1007/s00508-012-0160-y.
   PubMed Web of Science ®Google Scholar
• Bentley TG, Palta M, Paulsen AJ, et al. Race and gender associations between obesity and nine health-related quality-of-life measures. Qual Life Res. 2011;20:665–674. doi:10.1007/s11136-011-9878-7.
   PubMed Web of Science ®Google Scholar
• Kleinschmidt JJ, Digre KB, Hanover R. Idiopathic intracranial hypertension relationship to depression, anxiety, and quality of life. Neurology. 2000;54(2):319. doi:10.1212/WNL.54.2.319.
   PubMed Web of Science ®Google Scholar
• Mulla Y, Markey KA, Woolley RL, et al. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16(45):1–7. doi:10.1186/s10194-015-0521-9.
   PubMed Web of Science ®Google Scholar
• Bruce BB, Digre KB, Kathleen B, et al. On behalf of the NORDIC idiopathic intracranial hypertension study group quality of life at 6 months in the idiopathic intracranial hypertension treatment trial. Neurology. 2016;87:1871–1877. doi:10.1212/WNL.0000000000003280.
   PubMed Web of Science ®Google Scholar
• Kattah JC, Pula JH, Mejico LJ, et al. CSF pressure, papilledema grade, and response to acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neurol. 2015;262(10):2271–2274. doi:10.1007/s00415-015-7838-9.
   PubMed Web of Science ®Google Scholar
• Thaller M, Tsermoulas G, Sun R, et al. Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2021;92(7):795–797. doi:10.1136/jnnp-2020-325519.
   PubMed Web of Science ®Google Scholar
• Smith M, Nakamoto M, Crocker J, et al. Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: results of a quality improvement survey. Headache. 2021;61(1):149–156. doi:10.1111/head.14030.
   PubMed Web of Science ®Google Scholar
• Costabile T, Carotenuto A, Lavorgna L, et al. COVID-19 pandemic and mental distress in multiple sclerosis: implications for clinical management. Eur J Neurol. 2021;28(10):3375–3383. doi:10.1111/ene.14580.
   PubMed Web of Science ®Google Scholar
• Tashakori-Miyanroudi M, Souresrafil A, Hashemi P, et al. Prevalence of depression, anxiety and psychological distress in patients with epilepsy during COVID-19: a systematic review. Epilepsy Behav. 2021;125:108410. doi:10.1016/j.yebeh.2021.108410.
   PubMed Web of Science ®Google Scholar
• Shalash A, Roushdy T, Essam M, et al. Mental health, physical activity, and quality of life in Parkinson’s disease during COVID-19 pandemic. Mov Disord. 2020;35(7):1097–1099. doi:10.1002/mds.28134.
   PubMed Web of Science ®Google Scholar
• Capuano R, Altieri M, Bisecco A, et al. Psychological consequences of COVID- 19 pandemic in Italian MS patients: signs of resilience? J Neurol. 2021;268(3):743–750. doi:10.1007/s00415-020-10099-9.
   PubMed Web of Science ®Google Scholar